-
Souring On SUCRAs: When Treatment Ranking Goes Wrong
Oct 6, 2022, 15:25 PM -
On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data
Sep 30, 2022, 16:50 PM -
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
Sep 30, 2022, 16:11 PM -
Network Meta-Analysis - Special Topics
Sep 22, 2022, 13:41 PM -
Clinical Outcome Assessments in the Asia Pacific Region: Strategy & Implementation
Sep 16, 2022, 09:47 AM -
How Can Society Sustainably Benefit From Biosimilars? Global Learnings and Policy Recommendations for Australia
Sep 15, 2022, 19:16 PM -
An Introduction to Network Meta-Analysis
Sep 8, 2022, 12:33 PM -
Differentiating Between Patient Preferences, Patient Reported Outcomes and Patient Engagement
Sep 8, 2022, 10:26 AM -
Serving on the ISPOR Board- A Workshop for ISPOR Leaders
Aug 31, 2022, 13:16 PM -
ISPOR Asia Pacific Region Student Webinar: Health Technology Assessment and Market Access
Aug 25, 2022, 18:15 PM -
Stakeholder Engagement in Value Assessment
Aug 10, 2022, 10:18 AM -
Data Privacy and Digital Health: The Manufacturers/Payers Perspective
Jul 28, 2022, 10:00 AM -
Financing Sustainable Healthcare Systems in Latin America
Jul 7, 2022, 14:39 PM -
Distributional Cost-Effectiveness Analysis to Inform Healthcare Decisions
Jun 24, 2022, 11:40 AM -
About your Society- For ISPOR Leaders
Jun 16, 2022, 15:02 PM -
Oncology Endpoints in Reimbursement Decision-Making: Are We Keeping Pace With the Science?
Jun 16, 2022, 13:28 PM -
Sustainable Access to Biosimilars in the USA and Latin America: Challenges and Potential Solutions
Jun 10, 2022, 07:54 AM -
Patient-focused Endpoints Developing and Analyzing PRO Endpoints for Optimal Interpretability
May 20, 2022, 12:27 PM -
The Convergence of Synthetic Data and Self-Service Analytics to Create a New RWE Model
May 6, 2022, 11:29 AM -
Accelerating Patient Access to Next Generation Sequencing
May 4, 2022, 11:15 AM